aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.
| Revenue (TTM) | $586.53M |
| Gross Profit (TTM) | $575.54M |
| EBITDA | $-98.02M |
| Operating Margin | 9.56% |
| Return on Equity | -26.10% |
| Return on Assets | -11.20% |
| Revenue/Share (TTM) | $16.21 |
| Book Value | $-1.45 |
| Price-to-Book | 4.14 |
| Price-to-Sales (TTM) | 3.71 |
| EV/Revenue | 2.614 |
| EV/EBITDA | 17.25 |
| Quarterly Earnings Growth (YoY) | -5.30% |
| Quarterly Revenue Growth (YoY) | 113.40% |
| Shares Outstanding | $41.98M |
| Float | $29.80M |
| % Insiders | 8.46% |
| % Institutions | 50.27% |
Volatility is currently expanding
Ethos Technologies remains a 'Buy', with robust 151% revenue growth and a PEG below 1x supporting a bullish thesis. Q3 saw revenue far exceed guidance, but margin compression emerged as third-party agent sales and brand advertising increased. Consensus 2027 EPS of $2.40 implies LIFE trades at 17x earnings, with a fair value target of $48–$53, or 17–30% upside.
Ethos Technologies delivered Q3 earnings that crushed estimates, with revenue up 151% and a third consecutive quarter of 100%+ growth. LIFE's capital-light, tech-driven platform is rapidly gaining share in a fragmented life insurance market, especially via third-party agent channels. Margins are compressed due to increased marketing and third-party mix, but cash generation remains robust, supporting a $100M buyback and strong balance sheet.
Third-quarter revenue grew 151% year over year to $235 million. Third-party channel revenue grew 209% year over year in third quarter.
Ethos Technologies Inc. (LIFE) Q3 2026 Earnings Call Transcript
Q3 Revenue grew 151 % year-over-year to $ 235 million Q3 Direct Channel Revenue grew 112 % year-over-year to $ 119 million Q3 Third-Party Channel Revenue grew 209 % year-over-year to $ 116 million AUSTIN, Texas, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Ethos (Nasdaq: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced its financial results for the third quarter ended September 30, 2026. "Q3 was a record quarter for Ethos.
LOS ANGELES--(BUSINESS WIRE)---- $LIFE--LIFE Investors Have Opportunity to Join Ethos Technologies Inc. Fraud Investigation with SBS Law.
Investors need to pay close attention to LIFE stock based on the movements in the options market lately.
NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ethos Technologies Inc. ("Ethos" or the "Company") (NASDAQ: LIFE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
AUSTIN, Texas, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Ethos Technologies Inc. (NASDAQ: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced that it will release its financial results for the third quarter of 2026, which ended September 30, 2026, following the close of U.S. financial markets on Monday, November 2, 2026. The company's earnings press release will be made available on the Ethos Investor Relations website at investors.ethos.com.
Austin Hankwtiz is joined by Peter Collis, co-founder and CEO of Ethos Technologies, to discuss how the company is transforming life insurance with instant online underwriting, why eight of nine life insurtech competitors have been shuttered, pivoted or acquired, and what's driving Ethos's 113% revenue growth.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on LIFE and any ticker you trade — then tracks every position and per-strategy win rate.
